The market for nutrition related to cancer is anticipated to be worth US$ 4.87 billion by 2033, up from a projected US$ 2.07 billion in 2023. Over the course of the forecast period, the demand for oncology nutrition market sales is anticipated to grow at an average annual rate of 8.9%.
In the dynamic landscape of oncology nutrition, the demand for medical nutrition therapy plays a pivotal role in elevating physical resilience, aiding in cancer treatment tolerance, and enhancing overall quality of life. Businesses engaged in contemporary oncology nutrition products are poised to benefit from the anticipated rise in the adoption of oncology nutrition, especially with the growing recognition of its role in addressing the decline in tolerance to cancer therapy. Additionally, the imperative role of nutritional screening and evaluation is highlighted as essential for identifying individuals at a higher risk of malnutrition, further emphasizing the significance of proactive nutritional strategies in the realm of cancer care.
The surge in nutritional waste and risk among cancer patients stands as a prominent catalyst propelling the growth of the cancer nutrition market. Market participants are actively exploring the benefits of adopting a multidisciplinary approach, where specialized oncology nutrition guidelines play a pivotal role in enhancing the quality of cancer care.
Anticipated advancements in research and development, coupled with the introduction of cutting-edge products tailored for cancer patients, are expected to contribute significantly to the growth of oncology nutrition companies in the foreseeable future. The formulation of essential products and exploration of new markets are poised to not only enhance the cancer nutrition patent landscape but also accelerate future market expansion.
With an expected market valuation of US$3.12 billion by the end of 2027, several key factors are projected to drive the market’s expansion in the coming years, including:
- Evolving Recommendations
- Rise in Observational Studies
- Increase in Global Clinical Trials
The growing utilization of nutritional assessment programs, particularly in the context of cancer cachexia and pre-cachexia, is foreseen to sustain the demand for oncology nutrition. Over the last decade, advancements in data-gathering methodologies for assessing the nutritional status of diverse patient profiles have paved the way for personalized oncology nutrition therapy, recognized as an optimal solution for malnutrition-prone cancer patients.
Competitive Landscape of the Oncology Nutrition Market
New product launches and continuous technological innovations are the key strategies adopted by prominent players in the oncology nutrition market. The healthcare systems organizations are changing due to new research and increased public knowledge of the advantages of oncology nutrition. Clinical nutritionists and oncologists are working more closely to improve oncology nutrition and treatment within the oncology nutrition sector.
The presence of competitors, new product debuts, and partnerships related to the industry under consideration all contribute to the market’s growth. According to the report, Esperer launched its nutrition development center in Hyderabad in 2020. The facility in Hyderabad is expected to house a variety of cohesive capabilities, such as investigative workrooms and product development sub-centers, with a dedicated laboratory for analyzing sensory components, packing, and taste.
The leading firms worldwide for oncology nutrition are focused on obtaining regulatory clearances, developing cutting-edge goods, introducing new products, and partnering with and acquiring other businesses. The global market for oncology nutrition is projected to expand due to these leading players’ tactics. The following are a few expansion methods used by companies in the oncology nutrition market:
- To increase its presence in medical nutrition, Nestle acquired the Allergan business in January 2020.
- Smartfish AS and B. Braun worked together to introduce Remune, a medicinal nutrition solution, in September 2019. In 2019 and 2020, B. Braun introduced Remune in over 20 nations. Several other markets in Europe, Asia, and South America followed.
- Ina, the intelligent nutrition helper, was introduced by CancerCare in collaboration with Savor Health in 2019. The Ina offers tailored, evidence-based nutrition counseling to help cancer patients eat well and stay fed during treatment.
- A three-chamber bag with a unique protein-to-energy ratio called mofKabiven additional Nitrogen was introduced by Fresenius Kabi AG in 2018 in Europe.
- The SmartPN tool was introduced in October 2018 by Baxter International Inc. and the American Society for Parenteral and Enteral Nutrition (ASPEN) to reduce clinical malnutrition.
Key Players in the Oncology Nutrition Market
- FMC Corporation
- Danone India
- Abbott
- Aceto
- B. Braun Melsungen AG
- Baxter
- Fresenius Kabi AG
- Global Health Products, Inc.
- Hormel Foods Corporation
- Mead Johnson & Company, LLC
- Meiji Holdings Co., Ltd
- Nestlé S.A.
- BioSig Technologies, Inc.
- Auris Health, Inc.
Key Segments
By Cancer Type:
- Head & Neck Cancer
- Stomach & Gastrointestinal Cancers
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Other cancers
By End Use:
- Hospitals & Clinics
- Home Care
- Others
By Region:
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific
- Latin America
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube